Tareen B. et al "A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy"   Int J Med Sci. 2008 Mar 24;5(2):62-7
†The statements on this Web site have not been evaluated by the Food and Drug Administration (FDA). And are not intended to diagnose, treat, cure or prevent disease. The information presented is not intended to replace medical advice or treatment from your own doctor or healthcare provider. Nothing presented here is intended as a substitute for prescription medication or any other medical treatment prescribed by your doctor.